Direct Current Neuromuscular Electrical Stimulation for Treatment of Peripheral Neuropathy
Public ClinicalTrials.gov record NCT05442021. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Impact of Direct Current Neuromuscular Electrical Stimulation on Physical Therapy Treatment of Peripheral Neuropathy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will compare two methods of electrical stimulation (alternating current and direct current) as an adjunctive therapy to treating peripheral neuropathy. Both types of electrical stimulation have been used in clinical practice for physical therapy, however direct current stimulation is much less common and there is less known about their impact on physical therapy outcomes. The aim of this project is to show the efficacy of a novel device, the Neubie direct current device, compared to traditional TENS unit, in clinical physical therapy treatment of neuropathy. Outcomes measured will include three methods of two-point discrimination, vibration sense, pain, and score on the modified Toronto Clinical Neuropathy scale.
Study identification
- NCT ID
- NCT05442021
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 148 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 1, 2022 (Actual)
- Primary completion
- May 20, 2023 (Actual)
- Completion
- May 20, 2023 (Actual)
- Last update posted
- May 25, 2023
2022 – 2023
United States locations
- U.S. sites
- 11
- U.S. states
- 6
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| APEX Physical Therapy | Cape Coral | Florida | 33991 | — |
| Catalyst Physical Therapy | Clearwater | Florida | 33756 | — |
| APEX Physical Therapy | Fort Myers | Florida | 33908 | — |
| Diagnostic Solutions | Springfield | Kentucky | 40069 | — |
| Hands-On Physical Therapy | Astoria | New York | 11106 | — |
| Hands-On Physical Therapy of Queens Village | Queens Village | New York | 11428 | — |
| Panetta Physical Therapy & Diagnostics | Ronkonkoma | New York | 11779 | — |
| Courcier Physical Therapy | Edmond | Oklahoma | 73013 | — |
| Spine & Rehab Specialists | El Paso | Texas | 79936 | — |
| Active Fitness Physical Therapy | Oak Hill | West Virginia | 25901 | — |
| Active Fitness Physical Therapy | Victor | West Virginia | 25938 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05442021, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 25, 2023 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05442021 live on ClinicalTrials.gov.